RankingsPricing
  1. JP-listed companies
  2. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
  3. Financials
  4. Total current assets

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.JP:2395

Market cap
¥78.5B
P/E ratio
22.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 202532,940+6.82%
Mar 31, 202430,838+29.03%
Mar 31, 202323,900+48.13%
Mar 31, 202216,134+9.16%
Mar 31, 202114,780+19.10%
Mar 31, 202012,410+6.37%
Mar 31, 201911,666-23.70%
Mar 31, 201815,290-15.74%
Mar 31, 201718,146+11.29%
Mar 31, 201616,306-14.23%
Mar 31, 201519,011

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)